NOL12
gene geneOn this page
Also known as MGC3731Nop25RRP17
Summary
NOL12 (nucleolar protein 12, HGNC:28585) is a protein-coding gene on chromosome 22q13.1, encoding Nucleolar protein 12 (Q9UGY1). Multifunctional RNA binding protein that plays a role in RNA metabolism and DNA maintenance. It is a selective cancer dependency (DepMap: 79.6% of cell lines).
Enables identical protein binding activity. Predicted to be located in cytoplasm and nucleus. Predicted to be active in nucleolus.
Source: NCBI Gene 79159 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 55 total
- Cancer dependency (DepMap): dependent in 79.6% of screened cell lines
- MANE Select transcript:
NM_024313
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28585 |
| Approved symbol | NOL12 |
| Name | nucleolar protein 12 |
| Location | 22q13.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC3731, Nop25, RRP17 |
| Ensembl gene | ENSG00000273899 |
| Ensembl biotype | protein_coding |
| Entrez | 79159 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 3 protein_coding, 3 retained_intron, 1 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000359114, ENST00000438329, ENST00000468597, ENST00000474032, ENST00000484650, ENST00000493862, ENST00000611699, ENST00000902787
RefSeq mRNA: 1 — MANE Select: NM_024313
NM_024313
CCDS: CCDS13955
Canonical transcript exons
ENST00000359114 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001410571 | 37691174 | 37693474 |
| ENSE00003721469 | 37690697 | 37690794 |
| ENSE00003731400 | 37688850 | 37688992 |
| ENSE00003737060 | 37687910 | 37688015 |
| ENSE00003752271 | 37688312 | 37688360 |
| ENSE00003850306 | 37686343 | 37686475 |
Expression profiles
Bgee: expression breadth ubiquitous, 197 present calls, max score 92.21.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 21.2167 / max 163.6229, expressed in 1810 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 192183 | 16.9141 | 1810 |
| 192184 | 4.2661 | 1625 |
| 192182 | 0.0235 | 3 |
| 192180 | 0.0082 | 3 |
| 192181 | 0.0047 | 3 |
Top tissues by expression
266 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sural nerve | UBERON:0015488 | 92.21 | gold quality |
| right testis | UBERON:0004534 | 92.07 | gold quality |
| left testis | UBERON:0004533 | 91.91 | gold quality |
| monocyte | CL:0000576 | 91.79 | gold quality |
| mononuclear cell | CL:0000842 | 91.41 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 91.34 | gold quality |
| leukocyte | CL:0000738 | 91.02 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 90.52 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 89.62 | gold quality |
| right adrenal gland | UBERON:0001233 | 89.56 | gold quality |
| esophagus mucosa | UBERON:0002469 | 89.32 | gold quality |
| granulocyte | CL:0000094 | 89.19 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 89.18 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 89.15 | gold quality |
| left adrenal gland | UBERON:0001234 | 89.12 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 89.09 | gold quality |
| cerebellar cortex | UBERON:0002129 | 89.07 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 88.83 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 88.11 | gold quality |
| transverse colon | UBERON:0001157 | 87.67 | gold quality |
| testis | UBERON:0000473 | 87.43 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 87.39 | gold quality |
| adrenal cortex | UBERON:0001235 | 87.05 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 87.00 | gold quality |
| cingulate cortex | UBERON:0003027 | 86.84 | gold quality |
| right frontal lobe | UBERON:0002810 | 86.66 | gold quality |
| cerebellum | UBERON:0002037 | 86.65 | gold quality |
| ectocervix | UBERON:0012249 | 86.55 | gold quality |
| skin of abdomen | UBERON:0001416 | 86.53 | gold quality |
| minor salivary gland | UBERON:0001830 | 86.47 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.36 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
33 targeting NOL12, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-200B-3P | 100.00 | 73.31 | 2693 |
| HSA-MIR-200C-3P | 100.00 | 73.35 | 2685 |
| HSA-MIR-429 | 100.00 | 73.44 | 2698 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-3680-3P | 99.75 | 72.51 | 3095 |
| HSA-MIR-4306 | 99.72 | 70.50 | 3630 |
| HSA-MIR-3202 | 99.66 | 67.70 | 2737 |
| HSA-MIR-6715B-5P | 99.64 | 69.63 | 1420 |
| HSA-MIR-4663 | 99.62 | 65.33 | 957 |
| HSA-MIR-4269 | 99.55 | 69.89 | 1373 |
| HSA-MIR-6733-3P | 99.54 | 67.80 | 1281 |
| HSA-MIR-1207-5P | 99.49 | 69.11 | 2983 |
| HSA-MIR-4441 | 99.49 | 66.56 | 3216 |
| HSA-MIR-185-5P | 99.35 | 68.60 | 2497 |
| HSA-MIR-504-3P | 99.30 | 67.18 | 1745 |
| HSA-MIR-5589-3P | 99.29 | 68.30 | 1443 |
| HSA-MIR-3692-5P | 99.29 | 67.04 | 1421 |
| HSA-MIR-5582-5P | 99.27 | 71.42 | 1879 |
| HSA-MIR-6852-5P | 99.17 | 66.69 | 2073 |
| HSA-MIR-4763-3P | 99.10 | 67.83 | 2649 |
| HSA-MIR-1909-5P | 98.94 | 64.01 | 484 |
| HSA-MIR-6760-5P | 98.87 | 66.73 | 1515 |
| HSA-MIR-6715B-3P | 98.80 | 68.07 | 1204 |
| HSA-MIR-3135B | 98.61 | 65.33 | 1470 |
| HSA-MIR-4726-3P | 98.49 | 63.89 | 1385 |
| HSA-MIR-7156-3P | 98.25 | 67.66 | 859 |
| HSA-MIR-4664-5P | 98.17 | 65.07 | 1020 |
| HSA-MIR-6765-3P | 97.83 | 64.59 | 1165 |
| HSA-MIR-194-3P | 97.36 | 65.96 | 1027 |
| HSA-MIR-342-5P | 97.25 | 64.10 | 817 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 79.6% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 3)
- Nol12 is an RNA binding protein required for both ribosome maturation and genome integrity (PMID:29069457)
- Results show that NOL12 is important for nucleolar homeostasis, regulating its structure and the nucleolar levels of the multifunctional fibrillarin and nucleolin proteins. Moreover, NOL12 depletion to induce strong p53 activation leading to cell senescence suggesting an important role for NOL12 in replicative and chronological aging and its potential as aging biomarker. (PMID:30988155)
- The human cellular protein NoL12 is a specific partner of the HIV-1 nucleocapsid protein NCp7. (PMID:37695057)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | nol12 | ENSDARG00000038027 |
| mus_musculus | Nol12 | ENSMUSG00000033099 |
| rattus_norvegicus | Nol12 | ENSRNOG00000010209 |
Protein
Protein identifiers
Nucleolar protein 12 — Q9UGY1 (reviewed: Q9UGY1)
All UniProt accessions (1): Q9UGY1
UniProt curated annotations — full annotation on UniProt →
Function. Multifunctional RNA binding protein that plays a role in RNA metabolism and DNA maintenance. Participates in the resolution of DNA stress and the maintenance of genome integrity by localizing to sites of DNA insults. Also plays a role in proper nucleolar organization by limiting nucleolar size and regulating nucleolar number. Mechanistically, regulates the nucleolar levels of fibrillarin and nucleolin, two key players in pre-rRNA processing and ribosome assembly.
Subunit / interactions. Interacts with KIAA1191.
Subcellular location. Nucleus. Nucleolus. Cytoplasm.
Similarity. Belongs to the RRP17 family.
RefSeq proteins (1): NP_077289* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR019186 | Nucleolar_protein_12 | Family |
Pfam: PF09805
UniProt features (7 total): compositionally biased region 2, mutagenesis site 2, chain 1, region of interest 1, coiled-coil region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9UGY1-F1 | 74.94 | 0.31 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Mutagenesis-validated functional residues (2):
| Position | Phenotype |
|---|---|
| 21 | loss of dna damage response pathway activation. |
| 23 | loss of dna damage response pathway activation. |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-6791226 | Major pathway of rRNA processing in the nucleolus and cytosol |
MSigDB gene sets: 108 (showing top):
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2, TATA_C, DOUGLAS_BMI1_TARGETS_UP, MODULE_397, GOMF_SINGLE_STRANDED_DNA_BINDING, REACTOME_METABOLISM_OF_RNA, chr22q13, GOCC_NUCLEOLUS, SCGGAAGY_ELK1_02, MGGAAGTG_GABP_B, GEORGES_TARGETS_OF_MIR192_AND_MIR215, MANALO_HYPOXIA_DN, GOMF_RRNA_BINDING, AKT_UP_MTOR_DN.V1_UP, SRC_UP.V1_DN
GO Biological Process (0):
GO Molecular Function (5): single-stranded DNA binding (GO:0003697), RNA binding (GO:0003723), rRNA binding (GO:0019843), identical protein binding (GO:0042802), protein binding (GO:0005515)
GO Cellular Component (3): nucleolus (GO:0005730), cytoplasm (GO:0005737), nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| rRNA processing in the nucleus and cytosol | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| DNA binding | 1 |
| nucleic acid binding | 1 |
| RNA binding | 1 |
| protein binding | 1 |
| binding | 1 |
| nuclear lumen | 1 |
| intracellular membraneless organelle | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
1326 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| NOL12 | BOP1 | Q14137 | 615 |
| NOL12 | RRP1 | P56182 | 531 |
| NOL12 | EBNA1BP2 | Q99848 | 528 |
| NOL12 | RRP7A | Q9Y3A4 | 493 |
| NOL12 | RBM28 | Q9NW13 | 478 |
| NOL12 | NOL6 | Q9H6R4 | 474 |
| NOL12 | XRN2 | Q9H0D6 | 473 |
| NOL12 | WDR12 | Q9GZL7 | 460 |
| NOL12 | RBMX | P38159 | 433 |
| NOL12 | UTP18 | Q9Y5J1 | 431 |
| NOL12 | A0A0A6YYI9 | A0A0A6YYI9 | 425 |
| NOL12 | KIAA1191 | Q96A73 | 422 |
| NOL12 | RPF2 | Q9H7B2 | 421 |
| NOL12 | NOP56 | O00567 | 411 |
| NOL12 | RBM14 | Q96PK6 | 410 |
IntAct
126 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CEP70 | NOL12 | psi-mi:“MI:0915”(physical association) | 0.670 |
| NOL12 | CEP70 | psi-mi:“MI:0915”(physical association) | 0.670 |
| H1-1 | RRP8 | psi-mi:“MI:0914”(association) | 0.640 |
| NOL12 | RRP8 | psi-mi:“MI:0914”(association) | 0.640 |
| RPL7A | NOP56 | psi-mi:“MI:0914”(association) | 0.640 |
| NPM1 | MPHOSPH10 | psi-mi:“MI:0914”(association) | 0.610 |
| KRTAP10-7 | NOL12 | psi-mi:“MI:0915”(physical association) | 0.560 |
| DVL3 | NOL12 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SSX2IP | NOL12 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NOL12 | KRTAP10-7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NOL12 | DVL3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NOL12 | SSX2IP | psi-mi:“MI:0915”(physical association) | 0.560 |
| CDCA7L | NOL12 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MCC | NOL12 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-6 | NOL12 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TSPYL2 | NOL12 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BEND7 | NOL12 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPANXN2 | NOL12 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NOL12 | NOL12 | psi-mi:“MI:0915”(physical association) | 0.560 |
| H1-6 | ZNF724 | psi-mi:“MI:0914”(association) | 0.530 |
| MAK16 | NVL | psi-mi:“MI:0914”(association) | 0.530 |
| ZCRB1 | DKC1 | psi-mi:“MI:0914”(association) | 0.530 |
| BHLHA15 | RPLP0 | psi-mi:“MI:0914”(association) | 0.530 |
BioGRID (248): NOL12 (Two-hybrid), CEP70 (Two-hybrid), SSX2IP (Two-hybrid), KRTAP10-7 (Two-hybrid), NOL12 (Affinity Capture-MS), LARP7 (Affinity Capture-MS), CCDC137 (Affinity Capture-MS), KNOP1 (Affinity Capture-MS), RBM28 (Affinity Capture-MS), SF3B1 (Affinity Capture-MS), MRPS9 (Affinity Capture-MS), FTSJ3 (Affinity Capture-MS), MRPS26 (Affinity Capture-MS), SF3B2 (Affinity Capture-MS), DDX50 (Affinity Capture-MS)
ESM2 similar proteins: A1A5P2, A6QNR1, A8WY26, D3ZND0, O15213, O59678, P27672, P78316, Q0V8M0, Q15050, Q24K12, Q28IV8, Q2KIH4, Q2KII6, Q3T0Q8, Q3T0Z5, Q3UFY0, Q4KLC4, Q5M985, Q5RAS1, Q5RJT2, Q5TAP6, Q5TJE7, Q5ZKM1, Q640M1, Q6EJB6, Q6P0I6, Q6PFJ1, Q8BK35, Q8IY81, Q8N9T8, Q8NEJ9, Q8R3N1, Q8VDQ9, Q96BZ8, Q96EU6, Q9BRP8, Q9BRR8, Q9BVJ6, Q9C086
Diamond homologs: O14012, Q04031, Q0IH29, Q2KIV0, Q5D1Z3, Q5RD68, Q640V3, Q8BG17, Q9UGY1, Q7ZWE7
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 108 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Eukaryotic Translation Initiation | 8 | 35.8× | 7e-10 |
| Cap-dependent Translation Initiation | 8 | 35.8× | 7e-10 |
| SARS-CoV-1 modulates host translation machinery | 8 | 35.8× | 7e-10 |
| Peptide chain elongation | 19 | 34.9× | 6e-23 |
| Viral mRNA Translation | 19 | 34.9× | 6e-23 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | 19 | 34.6× | 6e-23 |
| Selenocysteine synthesis | 19 | 33.1× | 9e-23 |
| Eukaryotic Translation Termination | 19 | 33.1× | 9e-23 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| cytoplasmic translation | 20 | 38.2× | 4e-24 |
| ribosomal large subunit biogenesis | 7 | 32.0× | 2e-07 |
| ribosomal small subunit biogenesis | 11 | 25.8× | 5e-11 |
| rRNA processing | 14 | 20.4× | 9e-13 |
| translation | 19 | 20.1× | 2e-17 |
| RNA processing | 5 | 11.3× | 3e-03 |
| nucleosome assembly | 7 | 10.1× | 3e-04 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
55 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 41 |
| Likely benign | 2 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1174 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 22:37686473:GCG:G | donor_gain | 1.0000 |
| 22:37686474:CGGTG:C | donor_loss | 1.0000 |
| 22:37686476:G:C | donor_loss | 1.0000 |
| 22:37686476:G:GG | donor_gain | 1.0000 |
| 22:37686476:GTGA:G | donor_loss | 1.0000 |
| 22:37686477:T:A | donor_loss | 1.0000 |
| 22:37686477:T:G | donor_loss | 1.0000 |
| 22:37687893:C:A | acceptor_gain | 1.0000 |
| 22:37687906:GTA:G | acceptor_loss | 1.0000 |
| 22:37687907:TAGGG:T | acceptor_gain | 1.0000 |
| 22:37687908:A:AC | acceptor_loss | 1.0000 |
| 22:37687908:A:AT | acceptor_loss | 1.0000 |
| 22:37687908:AG:A | acceptor_gain | 1.0000 |
| 22:37687908:AGGGA:A | acceptor_gain | 1.0000 |
| 22:37687909:G:GT | acceptor_gain | 1.0000 |
| 22:37687909:G:T | acceptor_loss | 1.0000 |
| 22:37687909:GG:G | acceptor_gain | 1.0000 |
| 22:37687909:GGGA:G | acceptor_gain | 1.0000 |
| 22:37687909:GGGAG:G | acceptor_gain | 1.0000 |
| 22:37688000:G:GT | donor_gain | 1.0000 |
| 22:37688012:GGAG:G | donor_gain | 1.0000 |
| 22:37688013:G:GT | donor_gain | 1.0000 |
| 22:37688013:GAG:G | donor_gain | 1.0000 |
| 22:37688016:G:GA | donor_loss | 1.0000 |
| 22:37688016:G:GG | donor_gain | 1.0000 |
| 22:37688301:T:TA | acceptor_gain | 1.0000 |
| 22:37688303:T:TA | acceptor_gain | 1.0000 |
| 22:37688304:G:A | acceptor_gain | 1.0000 |
| 22:37688308:TCAGC:T | acceptor_loss | 1.0000 |
| 22:37688309:CAGC:C | acceptor_loss | 1.0000 |
AlphaMissense
1365 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 22:37687926:T:C | F34L | 0.999 |
| 22:37687928:C:A | F34L | 0.999 |
| 22:37687928:C:G | F34L | 0.999 |
| 22:37688925:T:A | V105D | 0.998 |
| 22:37686456:T:C | F22L | 0.997 |
| 22:37686458:C:A | F22L | 0.997 |
| 22:37686458:C:G | F22L | 0.997 |
| 22:37687927:T:C | F34S | 0.997 |
| 22:37687948:G:C | R41P | 0.996 |
| 22:37687915:A:C | Y30S | 0.995 |
| 22:37687929:C:G | H35D | 0.994 |
| 22:37686473:G:C | R27S | 0.993 |
| 22:37686473:G:T | R27S | 0.993 |
| 22:37687914:T:G | Y30D | 0.993 |
| 22:37687924:G:A | G33D | 0.993 |
| 22:37687936:G:C | R37P | 0.993 |
| 22:37688313:G:C | R64P | 0.993 |
| 22:37686472:G:T | R27M | 0.992 |
| 22:37687959:G:C | A45P | 0.992 |
| 22:37686457:T:C | F22S | 0.991 |
| 22:37687927:T:G | F34C | 0.991 |
| 22:37688931:T:A | V107E | 0.991 |
| 22:37687960:C:A | A45D | 0.990 |
| 22:37686472:G:C | R27T | 0.989 |
| 22:37687914:T:A | Y30N | 0.989 |
| 22:37687923:G:C | G33R | 0.989 |
| 22:37687952:G:C | K42N | 0.989 |
| 22:37687952:G:T | K42N | 0.989 |
| 22:37687914:T:C | Y30H | 0.987 |
| 22:37687935:C:G | R37G | 0.987 |
dbSNP variants (sampled 300 via entrez): RS1000819859 (22:37690157 G>A), RS1000875917 (22:37686765 C>G,T), RS1000890775 (22:37690451 T>C), RS1001241854 (22:37685460 A>C), RS1001640954 (22:37686268 G>A), RS1002007416 (22:37688250 C>A,G,T), RS1002205971 (22:37690892 C>A,G,T), RS1002627490 (22:37685852 T>C), RS1002674965 (22:37686215 G>C,T), RS1003570283 (22:37693020 G>A,C,T), RS1003629499 (22:37686997 G>A), RS1003682028 (22:37687161 G>A,T), RS1003701614 (22:37688146 G>A), RS1003925933 (22:37691758 C>T), RS1003980367 (22:37692500 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006629_43 | Pulse pressure | 5.000000e-11 |
| GCST010703_11 | Brain morphology (MOSTest) | 9.000000e-10 |
| GCST90002379_171 | Basophil count | 6.000000e-11 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005763 | pulse pressure measurement |
| EFO:0004346 | neuroimaging measurement |
| EFO:0005090 | basophil count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
21 total (human), top 21 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | decreases expression, increases expression | 2 |
| FR900359 | affects phosphorylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | decreases expression | 1 |
| trichostatin A | affects expression | 1 |
| sodium arsenite | decreases expression | 1 |
| abrine | increases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Air Pollutants | affects expression, increases abundance | 1 |
| Atrazine | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Caffeine | affects phosphorylation | 1 |
| Carbamazepine | affects expression | 1 |
| Copper | affects binding, decreases expression | 1 |
| Disulfiram | decreases expression, affects binding | 1 |
| Doxorubicin | increases expression | 1 |
| Ozone | increases abundance, affects expression | 1 |
| Quercetin | decreases phosphorylation | 1 |
| Ribonucleotides | affects binding | 1 |
| Vincristine | decreases expression | 1 |
| Cyclosporine | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.